XM does not provide services to residents of the United States of America.

Boeing investigates quality problem on undelivered 787s -sources



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>EXCLUSIVE-Boeing investigates quality problem on undelivered 787s -sources</title></head><body>

By Tim Hepher, David Shepardson and Allison Lampert

PARIS/WASHINGTON/MONTREAL, June 13 (Reuters) -Boeing BA.N is investigating a new quality problem with its 787 Dreamliner after discovering that hundreds of fasteners have been incorrectly installed on the fuselages of some undelivered 787 Dreamliner jets, two people familiar with the matter said.

The latest in a series of manufacturing snags affecting the U.S. planemaker involves incorrect "torquing" or tightening in a Boeing plant of more than 900 fasteners per plane - split equally between both sides of the jet's mid-body, they said.

There is no immediate concern about flight safety but Boeing is working to understand what caused the problem and will decide how much if any rework needs to be done once its investigation is complete, the sources said, asking not to be identified.

The sources said the fasteners - which attach the carbon-composite skin to skeletal supports inside the fuselage called longerons - had been torqued from the wrong side.

Boeing confirmed the checks in response to a Reuters query.

"Our 787 team is checking fasteners in the side-of-body area of some undelivered 787 Dreamliner airplanes to ensure they meet our engineering specifications. The in-service fleet can continue to safely operate," a spokesperson said.

"We are taking the time necessary to ensure all airplanes meet our delivery standards prior to delivery. We are working closely with our customers and the FAA (Federal Aviation Administration) and keeping them updated.”

The Federal Aviation Administration did not immediately respond to a request for comment.

Deliveries have been running more slowly than usual after an earlier production slowdown but have not so far been paused, FlightRadar24 tracking data showed.



Reporting By Tim Hepher in Paris, David Shepardson in Washington and Allison Lampert in Montreal;Editing by Elaine Hardcastle

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.